Reactive sites of adzuki bean proteinase inhibitor II were determined by limited hydro lyses with catalytic amounts of trypsin [EC 3.4.21.4] and chymotrypsin [EC 3.4.21.1] at pH 3.0. Treatment of the trypsin-modified inhibitor with carboxypeptidase B [EC 3.4.12.3] released lysine from the inhibitor and led to complete loss of the activity for trypsin, virtually, without affecting the chymotrypsin-inhibitory activity. Limited hydrolysis with chymotrypsin resulted in a selective cleavage of a single tyrosyl peptide bond in the inhibitor, and treatment of this modified inhibitor with carboxypeptidase A [EC 3.4.12.2] abolished the chymotrypsininhibitory activity, having no effect on the trypsin-inhibitory activity. After reduction and S-carboxymethylation, the trypsin-and the chymotrypsin-modified inhibitors both could be separated into two components by gel-filtration on Sephadex G-50 and DEAE-cellulose chromatography.
and no other amino acid residues than serine as amino terminal residues.
Measurements of proteolytic and inhibitory activities. The proteolytic activities of trypsin and chymotrypsin were determined at 30°C and pH 7.6 by the modified Kunitz casein digestion method. 
RESULTS
Amino-terminal residues of the trypsin-and the chymotrypsin-modified inhibitor s Amino-terminal amino acids of the trypsinand the chymotrypsin-modified inhibitors were determined by the dinitrophenylation pro cedure.9) In the hydrolysate of the dinitro phenylated trypsin-modified preparation, 0.85 mol DNP-serine per mole of inhibitor were found, and 1.20mol DNP-serine were detected from the dinitrophenylated chymotrypsinmodified inhibitor. In a control experiment , 0.56mol of DNP-serine were found from the native inhibitor treated at pH 3 .0 without pro teinase. These values were not corrected for losses due to acid hydrolysis and paper chro matography. The above results suggest that a new amino-terminal serine residue is formed in each modified inhibitor and that approximately 50% of the inhibitor are cleaved at a specific site by trypsin and the limited cleav age by chymotrypsin occurs in the inhibitor completely. The site of peptide bond cleavage in trypsinmodified inhibitor II The trypsin-modified inhibitor, reduced and S-carboxymethylated according to Crestfield et a1.,10) was subjected to gel-filtration through Sephadex G-50. Fractions eluted faster in Fig. 1 -A are to contain a component of the intact inhibitor survived the trypsin modifi cation since the amino acid composition is very close to that of the native protein (data not given in this paper), and the component fragments of the modified inhibitor present in the later-effluent fractions. Fractions indi cated by a bar were pooled and separated into two components (T-1 and T-2 in Fig. 1-B) by DEAE-cellulose chromatography with a linear gradient from 0.0 to 0.5M NaCl in 0.05M Tris-HCl buffer (pH 8.0). Amino acid com positions of these components are given in Table II . A component, T-1, was composed of 27 residues and had serine residue as the amino-terminal residue and lysine as the car- Site of peptide bond cleavage in chymotrypsinmodzif ed inhibitor II The chymotrypsin-modified inhibitor, re duced and S-carboxymethylated, was separated itself into two fragments (C-1 and C-2 in Fig. 2 ) by gel-filtration through a Sephadex G-50 column using 0.2M acetic acid. Amino acid compositions of these fragments are given in Chemical modification of inhibitor II with Nbromosuccinimide The modification was performed in various ratios of N-bromosuccinimide to inhibitor at pH 4.0 and a room temperature. The de crease in absorbance at 280nm was followed to estimate degree of the modification, and remaining activities of the inhibitor were deter mined against trypsin and chymotrypsin. The results are shown in Fig. 3 . The decrease in the absorbance indicated that the modification of the tryptophan residue in the inhibitor attained to about 93% at the molar ratio of the reagent to inhibitor of 3.0. But, the modi fied inhibitor retained the activities against the both proteinases. •oe, - Iodination of inhibitor II One of the two tyrosine residues in the in hibitor was readily iodinated at pH 8.5 and its diiodo-derivative was formed.
This suggests that one tyrosine residue is exposed to solvent and the other is buried in the molecule. The inhibitory activity for trypsin underwent no influence of the iodination, and that for chymo trypsin remained by about 70% (Fig. 4) 
DISCUSSION
Proteinase inhibitor II from adzuki beans inhibits trypsin and chymotrypsin at separate reactive sites on its molecule, but not simul taneously, unlike limabean,14) Bowman-Birk and other double-headed inhibitors. Inhibitor II, which was subjected to limited proteolysis with trypsin and followed by treat ment with carboxypeptidase B, lost its ac tivity against trypsin, and then lysine was re leased from the new carboxyl-terminal of the inhibitor. This fact confirms the previous supposition" that the reactive site of the in hibitor for trypsin contains a lysine residue, since the chemical modification with trinitro benzenesulfonic acid inactivates the inhibitor against trypsin but not against chymotrypsin. Upon limited hydrolysis by chymotrypsin, a new carboxyl-terminal tyrosine residue was produced in the inhibitor. The residue is indispensable for chymotrypsin-inhibitory ac tivity of the inhibitor and not for trypsin -inhibitory activity because removal of the tyro sine residue by carboxypeptidase A abolishes the activity against chymotrypsin while allows the activity fully to remain against trypsin.
This chymotrypsin-reactive residue should be at the surface in contact with the sur rounding solvent and could be readily iodi nated. But iodination of the inhibitor was less effective on the inhibitory activity against chymotrypsin than expected from the results of the chymotrypsin-limited hydrolysis follow ed by carboxypeptidase A treatment. It may be explained that the iodinated tyrosine residue in the inhibitor can be still located in the sub strate-binding pocket of chymotrypsin mole cule or near the active center and interacts with chymotrypsin to some extent, as m-iodo phenylacetate or formyl p-iodophenylalanine does.19) Tryptophan and methionine residues in the inhibitor also are possible to interact with chymotrypsin. Upon the modification with N-bromosuccinimide, losses of activities against trypsin and chymotrypsin were not comparable to the amount of the modified tryptophan residue in the inhibitor. The try ptophan residue will not participate in the inhibitory mechanisms.
The modification with cyanogen bromide has a fatal effect on the trypsin-inhibitory activity of the inhi bitor and the chymotrypsin-inhibitory activity was very resistible against the treatment. Consequently, the methionine residue may oc cupy a part of binding regions necessary to keep the proper conformation which confers the full activity against trypsin, and may be located away from the active center against chymotrypsin, since the residue appears not to participate directly in the interaction with tryp sin judging from the specificity of the enzyme.
Amino acid compositions of the fragments from the trypsin-and the chymotrypsinmodified inhibitors and terminal analyses indi cate that the reactive peptide bond of the in hibitor for trypsin lies between residues Lys27 and Ser28 and that for chymotrypsin, between Tyr54 and Ser55. These reactive site positions are similar to those of lima bean proteinase inhibitor.20) Nevertheless, lima bean inhibitor inhibits trypsin and chymotrypsin simul taneously but a complex of our inhibitor with chymotrypsin does not inhibit trypsin. This discrepancy may be due to the conformational difference derived from a slight difference in amino acid composition between both in hibitors.
